These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 309726)

  • 21. [Acute initial manifestation of systemic lupus erythematosus in the puerperium].
    Kolben M; Rothdauscher G; Schweigart U; Graeff H
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):310-2. PubMed ID: 1860663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between immunological parameters and cutaneous manifestations of systemic lupus erythematosus.
    Levo Y; Pick AI; Nir MA; Weiss C; Feuerman EJ
    Dermatologica; 1973; 147(5):316-20. PubMed ID: 4132897
    [No Abstract]   [Full Text] [Related]  

  • 23. Systemic lupus erythematosus following meningococcal vaccination.
    Holmes AD; Abbasi OZ; Jacoby JL
    Am J Emerg Med; 2018 Jan; 36(1):170.e3-170.e4. PubMed ID: 29031481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission in systemic lupus erythematosus: durable remission is rare.
    Wilhelm TR; Magder LS; Petri M
    Ann Rheum Dis; 2017 Mar; 76(3):547-553. PubMed ID: 27558987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
    Wysocka K; Kiczak J
    Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
    [No Abstract]   [Full Text] [Related]  

  • 26. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant.
    Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM
    Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinogen-fibrin degradation products in glomerular diseases].
    Sasdelli M; Fabbri L; Cagnoli L; Zuccalà A
    Minerva Nefrol; 1973; 20(3):170-6. PubMed ID: 4761428
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation.
    Kageyama Y; Yagi T; Miyairi M
    Intern Med; 2002 Feb; 41(2):161-6. PubMed ID: 11868607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic difficulties in systemic lupus erythematosus].
    Jedrzejczak M; Burgielski R
    Pneumonol Alergol Pol; 1994; 62(5-6):290-4. PubMed ID: 7522726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):249-51. PubMed ID: 4115641
    [No Abstract]   [Full Text] [Related]  

  • 31. Left-handed "Z" DNA antibodies in rheumatoid arthritis and systemic lupus erythematosus.
    Sibley JT; Lee JS; Decoteau WE
    J Rheumatol; 1984 Oct; 11(5):633-7. PubMed ID: 6334742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K; Abeles M
    J Rheumatol; 1994 Sep; 21(9):1674-7. PubMed ID: 7799348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XII deficiency with systemic lupus erythematosus. Biological implications.
    Passero FC; Myers AR; Guerry D
    Arthritis Rheum; 1979 Apr; 22(4):419-22. PubMed ID: 426885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-DNA antibodies in systemic lupus erythematosus. Study of 2 methods of detection].
    Sepúlveda C; Rivero S; Jacobelli S
    Rev Med Chil; 1985 Feb; 113(2):89-93. PubMed ID: 3909284
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lupus erythematosus with muscular involvement and Raynaud's syndrome].
    Gajkowski K
    Neurol Neurochir Pol; 1974; 8(1):109-12. PubMed ID: 4135376
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood coagulation changes in systemic lupus erythematosus].
    Liu WL; Xiu HZ; Sun HY
    Zhonghua Nei Ke Za Zhi; 1990 Dec; 29(12):717-9, 764. PubMed ID: 2128740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membranous glomerulopathy in systemic lupus erythematosus.
    Gonzalez-Dettoni H; Tron F
    Adv Nephrol Necker Hosp; 1985; 14():347-64. PubMed ID: 3919538
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of determining the affinity of anti-native DNA antibodies in lupus nephritis].
    Asano Y
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):284-7. PubMed ID: 314546
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus.
    Tron F; Bach JF
    Clin Exp Immunol; 1977 Jun; 28(3):426-32. PubMed ID: 302165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.